Hin Sang Group (International) Holding Co. Ltd. has released its Annual Report for the year 2024/2025. The report highlights the company's continued focus on the marketing, selling, and manufacturing of healthcare products, primarily targeting children under the reputable "Hin Sang" brand. During the year, the Group maintained a strong market position in the children's healthcare sector by leveraging its core strengths and competitive advantages. There were no significant investments, acquisitions, or disposals of subsidiaries, associates, or joint ventures reported. The company has not outlined any specific plans for material investments or capital assets as of March 31, 2025. The full report can be accessed through the link below.